The White Powder and the Soft Drink
Cocaine was a medical marvel, a consumer product, and a corporate ingredient before it was a street drug. The institutions that built the market walked away from the population they created.
The White Powder and the Soft Drink is an analytical history of cocaine — tracing the compound from Andean coca leaves through Victorian patent medicines through the invention of Coca-Cola through the crack epidemic through the Colombian-to-Mexican cartel transition — and documenting how each institutional chapter created a market, walked away from the population it built, and handed the demand to whatever came next.
This essay is part of The Pharmacological State — a documented history of institutional pharmacology. Each piece stands alone. The history is the argument.
The Soldier and the Pharmacist
John Stith Pemberton was wounded at the Battle of Columbus on April 16, 1865 — one of the last engagements of the Civil War. He was a Confederate officer, fifty-three years old, and the wound left him in enough pain that army surgeons gave him morphine. He came home addicted.
He was not unusual. Tens of thousands of veterans on both sides came home from the Civil War dependent on the same compound. The Union Army alone had requisitioned over 10 million opium pills and nearly 2.8 million ounces of opium powders during the war. The condition had a name — Soldier's Disease. The institution that created it had no interest in treating it. The men went home with their dependence and found whatever the market offered.
Pemberton spent years trying to find a substitute. He was a pharmacist by training and an inventor by temperament. He had read about Vin Mariani — a French coca wine developed in 1863 by Corsican chemist Angelo Mariani, endorsed by Pope Leo XIII who reportedly carried a hip flask of it for those moments when prayer was insufficient, praised by Ulysses Grant who credited it with giving him the strength to write his memoirs while dying of throat cancer, touted by Thomas Edison. In the early 1880s Pemberton began developing his own version.
When Georgia passed prohibition legislation in 1886 he removed the alcohol. What remained was a coca-leaf syrup mixed with carbonated water — marketed as a cure for headaches, exhaustion, nerve disorders, and morphine addiction. His bookkeeper Frank Robinson named it and designed the script logo still in use today. Pemberton sold it at Jacob's Pharmacy in Atlanta for five cents a glass. In its first year it sold approximately nine drinks per day.
He had a hunch it would someday be a national drink. He was right. He didn't live to see it.
Sick with stomach cancer and increasingly addicted to morphine, he sold his rights across multiple transactions in 1888. The total paid by Atlanta pharmacist Asa Griggs Candler was approximately $2,300. Candler sold the company in 1919 for $25 million. The Coca-Cola Company is now worth approximately $249 billion. The formula — never patented, always kept secret — is held in a vault at the World of Coca-Cola museum in Atlanta, known only to a handful of anonymous employees. It is arguably the most valuable trade secret in corporate history.
Pemberton died on August 16, 1888, poor and addicted to morphine to the end. His son Charley — himself an alcoholic and opium addict — sold the name separately for $300. Six years later Charley was found unconscious with a stick of opium beside him. He died ten days later at age 40.
The man who created the most successful consumer product in history was a morphine addict looking for an exit the institutions that created his dependence never provided. He found one. He built it out of a different compound. His formula sold for $2,300. It is now worth more than the GDP of most countries. He died penniless. His son died the same way.
The Mountain
The coca plant has been in human hands for five thousand years.
The Inca chewed coca leaves before battle, before labor, before ceremony. At elevation — the Andes sit between 11,000 and 17,000 feet — coca counteracted altitude sickness, suppressed hunger, and extended endurance. It was woven into the social and religious fabric of Andean civilization so thoroughly that the Spanish conquistadors who arrived in the 1530s initially tried to ban it as a pagan practice. They reversed course when they discovered that the indigenous laborers forced to work their silver mines in Potosí worked harder and longer with coca than without it.
The Spanish didn't eliminate the plant. They industrialized it. Coca rations became a standard component of forced labor compensation in the colonial mining economy. The compound that the Inca had used in ceremony became an input cost in a silver extraction operation.
The pattern was already running — institution adopts pharmacological tool to serve operational objective, population absorbs the consequences — four hundred years before Bayer named anything heroic. Institutional Pharmacology
It took another three centuries for European chemistry to isolate what the coca leaf actually contained. In 1860 German chemist Albert Niemann extracted the alkaloid from the leaf, noted that it numbed his tongue on contact, and named it cocaine. He died the following year, twenty-six years old, before he could develop it further.
Some Latin American historians call what followed the revenge of the Incas — the compound the conquistadors exploited coming back to devastate the civilization that colonized the people who first grew it. The framing is poetic. The arc is documented.
The Wonder Drug
By the time Pemberton was mixing coca syrup in Atlanta, cocaine had already conquered European medicine.
Sigmund Freud published his first scientific paper on cocaine in 1884 — calling it a magical substance and recommending it for depression, sexual dysfunction, morphine addiction, and nervous exhaustion. He sent samples to his fiancée as a romantic gesture. He took it himself before social engagements to make himself more talkative. He spent twelve years addicted to it before he managed to stop — at which point his brain chemistry and physical health, by his own account, were permanently altered.
William Halsted — the founding surgeon at Johns Hopkins, credited with developing aseptic surgical technique and the radical mastectomy — injected cocaine into his own arms and legs to test its anesthetic properties. He became a non-functional addict within months. His colleagues noticed he was frequently late, refused eye contact, and avoided conversation. He was sent to a sanitarium twice. He continued using cocaine for thirty-eight years, until he died.
Carl Koller — a twenty-seven year old unpaid ophthalmology intern — used cocaine to perform the first successful local anesthesia in surgical history, dropping a cocaine solution into a patient's eye before operating. This was a genuine medical breakthrough. The compound that numbed the tongue also blocked surgical pain without the risks of chloroform and ether. The entire field of local anesthesia grew from that discovery.
German pharmaceutical company Merck produced 0.4 kilograms of cocaine in 1883. Two months after Koller's surgical report was published, their production rocketed to 83,343 kilograms. The medical establishment hadn't changed its assessment of the compound. The market had simply recognized the scale of the opportunity.
By the late 1880s cocaine was in patent medicines, toothache drops, throat lozenges, and hay fever remedies. It was distributed by Parke Davis in cigarettes, injectable solutions, and a portable cocaine kit complete with hypodermic needle. Queen Victoria reportedly used it. Pope Leo XIII carried Vin Mariani in a hip flask and awarded Angelo Mariani a Vatican gold medal. The compound the Inca had chewed for altitude endurance was now the fashionable stimulant of European royalty and the Catholic Church.
Nobody was lying about its effects. Cocaine worked. It suppressed hunger, elevated mood, extended endurance, and blocked pain. The problem — which the medical establishment was remarkably slow to name — was that it also produced dependence, paranoia, and psychosis with consistent reliability. Freud's colleague Ernst von Fleischl-Marxow, whom Freud had prescribed cocaine to treat his morphine addiction, developed the sensation of insects and snakes crawling beneath his skin — the first documented case of cocaine-induced formication. He died seven years later, addicted to both morphine and cocaine.
The medical establishment had a name for the most severe presentations — cocaine psychosis. Paranoid delusions. Auditory hallucinations. The sensation of insects crawling beneath the skin, a symptom so characteristic it acquired its own clinical name: formication. Halsted was sent to a sanitarium twice. It resolved nothing. The institution that had produced mass cocaine dependence through enthusiastic clinical endorsement had no treatment framework for what it had created. The sanitarium was medicine's acknowledgment that the problem was real and its admission that it had no answer.
The institution had identified a useful compound. It had distributed it at scale. It had not done the work of understanding what scale would produce.
The Market
Cocaine's medical endorsement was the supply chain. The patent medicine industry was the distribution network.
By the 1890s cocaine appeared in over-the-counter preparations for every imaginable complaint. Toothache drops. Hay fever remedies. Throat lozenges. Cough syrups. A preparation called Tucker's Asthma Specific — cocaine dissolved in alcohol — was advertised as safe for children. Parke Davis sold cocaine in cigarettes, injectable solutions, and a portable kit complete with hypodermic needle, marketed to physicians and adventurous laypeople alike. CF Boehringer distributed glass paperweights to physicians touting itself as the largest makers of quinine and cocaine in the world.
The consumer market had arrived at cocaine before anyone had honestly evaluated what a consumer market for cocaine would produce. The medical endorsement layer — Freud's papers, Halsted's surgical demonstrations, Koller's anesthetic breakthrough — gave the patent medicine industry institutional cover. If Freud recommended it for depression and Johns Hopkins surgeons used it in the operating room, who was a pharmacist to question its safety in a toothache remedy?
Coca-Cola sat at the center of this ecosystem — the most visible and most commercially successful cocaine delivery mechanism in American history, sold at five cents a glass to everyone from factory workers to society ladies. It was marketed simultaneously as a temperance drink, a brain tonic, and a cure for morphine addiction. It was all three, in the same way that heroin was a cure for morphine addiction — the new compound replacing the old one, the institutional language unchanged, the dependence potential unexamined.
The cocaine was removed from Coca-Cola in 1903. The formula was adjusted. The brand survived. The active ingredient that made it work in the first place is long gone. The brand it built persists.
The Harrison Narcotics Tax Act of 1914 did to cocaine what it did to opioids — it criminalized the dependent population rather than treating it. Physicians who had been legally maintaining dependent patients suddenly faced liability for doing so. The patients had nowhere to go. Cocaine use declined through the 1920s and 1930s — driven underground, expensive, difficult to obtain — and largely disappeared from American culture for fifty years.
The institution had created the market. The institution walked away. The demand waited.
The Return
Cocaine didn't disappear. It waited.
For fifty years — through Prohibition, the Depression, World War II, and the postwar boom — cocaine was a minor footnote in American drug culture. Expensive, scarce, difficult to obtain. The criminal infrastructure for distributing it at scale didn't exist yet.
Then in the late 1970s it came back. And it came back differently.
The Colombian Medellín Cartel — built by Pablo Escobar from a small smuggling operation into the most powerful criminal enterprise the Western hemisphere had produced — found a supply chain problem and solved it with industrial logic. Coca cultivation in Bolivia and Peru produced raw material. Colombian labs refined it into powder cocaine. Caribbean routes — through the Bahamas, through Miami — moved it into the United States. By the early 1980s cocaine was flooding American markets faster than demand could absorb it.
The price collapsed. Cocaine that had sold for $60,000 a kilogram in the late 1970s dropped to $12,000 by the mid-1980s — an 80 percent decline. The cartel had a commodity problem. Too much product, falling margins, a high-end market approaching saturation.
The solution was not to reduce supply. It was to engineer a new market.
Crack cocaine was not a chemistry discovery. The freebase conversion process had been known since the 1970s. What changed in 1984 and 1985 was the economic logic. Convert powder to crack and you could sell $5 rocks instead of $100 lines. You could reach populations that could never afford powder cocaine. You could create a product that produced a faster, shorter, more intense high — which meant users needed more of it, more often. Interval compression applied to a commodity.
The crack epidemic that followed was one of the most concentrated pharmacological catastrophes in American urban history. Specific communities — predominantly Black, predominantly poor, already structurally abandoned by deindustrialization and federal disinvestment — were saturated with a product precisely engineered for rapid dependence at low cost. The distribution network at the retail level ran through street gangs. The wholesale supply ran through Colombian cartels. And running alongside it — documented in congressional testimony and confirmed by the CIA's own Inspector General — was a supply chain the intelligence community knew about and protected.
The Kerry Committee in 1989 concluded that Contra supply networks were used by drug trafficking organizations and that Contra-linked individuals had sold cocaine into American cities while US government agencies looked away. The CIA's own Inspector General later confirmed awareness of the trafficking and acknowledged impeding DEA investigations into those networks.
Barry Seal — a former TWA pilot turned CIA and DEA asset — ran cocaine for the Medellín Cartel through Mena, Arkansas while simultaneously operating as a government informant. His operation is documented in court records and DEA files. He was assassinated in a Baton Rouge parking lot in February 1986 before he could testify fully before a congressional committee. The full scope of what Seal knew and what he had been authorized to do was never established in open testimony.
His story was not isolated. In Southeast Asia during the Vietnam era, Air America — the CIA's proprietary airline — flew weapons in and opium out of the Golden Triangle. The pattern of intelligence community operations intersecting with drug trafficking networks to fund activities that couldn't be funded through congressional appropriations was not an accident of geography or circumstance. It was a recurring operational convenience across multiple decades and theaters.
The institution that was supposed to be fighting the drug war was, in documented instances, using the drug trade to fight other wars. The population living inside the resulting epidemic absorbed the consequences of both.
The Handoff
The Colombian cartels that built the crack market didn't survive it.
Pablo Escobar was killed by Colombian security forces in December 1993. The Medellín Cartel collapsed around him. The Cali Cartel absorbed market share briefly before US-Colombian cooperation dismantled it in the mid-1990s as well. The Colombian organizations that had industrialized cocaine and engineered the crack epidemic were gone within a decade of crack's emergence.
The market they had built was not.
Mexican trafficking organizations had been working as couriers and logistics partners for the Colombian wholesale suppliers for decades. When the Colombian organizations fell, the Mexicans absorbed the wholesale role. They didn't take over cocaine production — Colombia still produces over 97 percent of the cocaine consumed in the United States, confirmed by DEA analysis as recently as 2024. What the Mexican cartels took over was the distribution infrastructure — the border crossings, the transit routes, the street-level networks that moved Colombian product into American cities.
They then improved on the Colombian model in one critical area. The Colombians had been agricultural — dependent on coca cultivation, vulnerable to eradication campaigns, constrained by geography. The Mexican cartels identified that dependency as a liability.
Methamphetamine was their first laboratory product. No crop required. No geography required. Precursor chemicals sourced from Asia, synthesis in Mexican labs, distribution through the same networks that moved cocaine. Then fentanyl — the logical endpoint of the synthetic model. Fifty times more potent than heroin. Derived entirely from precursor chemicals. A quantity that fits in an envelope capable of killing hundreds of people.
The precursor chemicals for fentanyl flow primarily from China. Chinese pharmaceutical companies — some with documented ties to the Chinese state, operating openly on the surveilled Chinese internet with export-focused narcotics content the CCP specifically leaves untouched while censoring domestic drug content — supply the chemical backbone of the fentanyl epidemic. The House Select Committee on the Chinese Communist Party concluded in a bipartisan 2024 investigation that the CCP subsidizes fentanyl precursor exports through tax rebates, protects fentanyl traffickers from prosecution, and directly benefits from the resulting crisis. One of China's own military strategists has explicitly discussed drug warfare that causes disasters in other countries while making huge profits as a strategic concept. The fentanyl epidemic is operating exactly as described.
The Inheritance
The arc from Pemberton to fentanyl runs through one continuous relay.
A Confederate soldier came home addicted to morphine from battlefield medicine and built a cocaine-based soft drink to treat his own dependence. The cocaine was medicalized, endorsed by the medical establishment at scale, distributed through patent medicine channels before anyone honestly evaluated what scale would produce. When the liability became visible the institution criminalized the dependent population and walked away. The street market inherited the demand.
Fifty years later the Colombian cartels industrialized cocaine supply, engineered crack as a market innovation when profits fell, and saturated specific communities through distribution networks the intelligence apparatus knew about and protected. When the Colombian organizations collapsed the Mexican cartels absorbed the wholesale role — not the production, Colombia still produces the cocaine — but the distribution infrastructure, the border crossings, the street networks. They then moved beyond agriculture entirely. Methamphetamine first. Then fentanyl.
The precursor quality tells its own story. Original cocaine processing used petroleum ether — a clean solvent producing purity around 90 percent. US interdiction of precursor chemicals forced substitution to gasoline, kerosene, diesel, and a crude stolen pipeline product called pategrillo that tops out at 75 percent purity. The War on Drugs made the product dirtier without reducing the supply. The people absorbing the degraded product absorbed that consequence too.
The population the institutional relay created — made opioid-sensitive by pharmaceutical medicine, abandoned to cartels when prescribing was restricted, now finding the retail market for novel partial agonists that pharmaceutical channels no longer provide — is the same population John Pemberton was trying to help when he put coca leaf extract in carbonated water in 1886.
The compound has changed at every stage. The population has not.
Related: